15-19 August 2011
Organisers: Stefanie Biedermann (Southampton), Vladimir Dragalin (Quintiles, USA), Sandra Eldridge (QMUL), Heiko Grossmann (QMUL), Michael Krams (Johnson & Johnson, USA) and Peter Mueller (Texas at Austin).
in association with the Newton Institute programme Design and Analysis of Experiments
(18 July - 21 December 2011)
The purpose of this workshop is to gather together people working in various aspects of design of experiments in health-care, in the widest understanding of that word, from drug development in pre-clinical and clinical trials, treatment individualization, studies on primary care, and gathering evidence for public policy, to choice experiments in health economics. Participants and speakers include experts from industry and academia. Several talks will specifically focus on challenges and problems arising with the practical implementation of proposed strategies. Presentations describing both the current attempts to use DoE to overcome the recognized inefficiencies of the traditional drug development as well as the new challenges in implementing the DoE in clinical trials will be a basis for exchange of information among the researchers from the pharmaceutical companies, regulatory authorities, and from academia.
Presentations will be organized in sessions around the following themes:
All participants are invited to submit abstracts for posters. Interested participants should indicate so on the application form and submit a title and abstract to firstname.lastname@example.org. Poster abstracts will not be accepted after the application deadline has passed.
Sessions will start on Monday 15 August 2011 at 9am and we envisage the last session to end at 4pm on Friday 19 August 2011.